好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

2009 Annual Meeting | Inflammatory, Necrotizing, and Autophagic Myopathies

Tuesday 04/28/09
02:00 PM - 03:30 PM Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Scientific Platform Session
Muscle Disease/Neuromuscular Junction
No CME available
Event Timeline
02:00 PM - 03:30 PM Abstract 001 - TDP-43 in Inflammatory Myopathies
02:00 PM - 03:30 PM Abstract 002 - Signal Recognition Particle 54kD Autoantibody (SRP54-IgG) and Accompanying Autoimmune Necrotizing Myopathy Identified Incidentally in Paraneoplastic Antibody Screening
02:00 PM - 03:30 PM Abstract 003 - Natural History of Idiopathic and Post-Exertional Rhabdomyolysis
02:00 PM - 03:30 PM Abstract 004 - Inhibited Lysosomal Activity in Sporadic Inclusion-Body Myositis (s-IBM) Muscle Fibers Is Associated with Increased Maturation of Autophagosomes and Accumulation of sequestosome1/p62 ([quot]p62[quot]) Immunopositive Inclusions
02:00 PM - 03:30 PM Abstract 005 - Hypomorphic Alleles of the VMA21 Gene Downregulate the V-ATPase and Cause X-Linked Myopathy with Excessive Autophagy
02:00 PM - 03:30 PM Abstract 006 - Treatment with Resveratrol, trans-3,4[apos],5-trihydroxystilbene Polyphenol Decreases Amyloid Beta Precursor Protein (A[beta]PP), Amyloid-[beta] (A[beta]) Oligomerization and Myostatin in A[beta]PP-Overexpressing Cultured Human Muscle Fibers (A[beta]PP[sup]+[/sup]-CHMF[ndash]IBM Model): Relevance to Treatment of Sporadic-IBM Patients
Faculty Disclosures
Steven A. Greenberg, MD Dr. Greenberg has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abcuro, Inc.. Dr. Greenberg has stock in Abcuro. Dr. Greenberg has received intellectual property interests from a discovery or technology relating to health care.
Marinos C. Dalakas, MD, FAAN Dr. Dalakas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Grifols, . Dr. Dalakas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx,. Dr. Dalakas has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Dysimmune Diseases Foundation. Dr. Dalakas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Serono. Dr. Dalakas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Dalakas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Dalakas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Octapharma. Dr. Dalakas has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Kyverna. Dr. Dalakas has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ARGENX. Dr. Dalakas has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. Dr. Dalakas has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Dalakas has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Therapeutic Advances in Neurology (TAND). Dr. Dalakas has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Medlink.
Anna Nogalska, PhD No disclosure on file
George R. Wilmot, MD, PhD Dr. Wilmot has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Larimar Therapeutics. The institution of Dr. Wilmot has received research support from Friedrich Ataxia Research Alliance. The institution of Dr. Wilmot has received research support from National Ataxia Foundation. The institution of Dr. Wilmot has received research support from NIH. The institution of Dr. Wilmot has received research support from Reata. The institution of Dr. Wilmot has received research support from Biohaven Pharmaceuticals.
W. K. Engel, MD, FAAN No disclosure on file
Carla D'Agostino, PhD No disclosure on file
Valerie Askanas, MD, PhD, FAAN No disclosure on file
No disclosure on file
Mitsuhiro Yoshita, MD, PhD No disclosure on file
Joshua P. Alpers, MD Dr. Alpers has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Argenx. Dr. Alpers has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. Dr. Alpers has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Alpers has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Argenx. Dr. Alpers has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Alpers has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for UCB.
Andrew McKeon, MD The institution of Dr. McKeon has received research support from National Institutes of Health. Dr. McKeon has received intellectual property interests from a discovery or technology relating to health care. Dr. McKeon has received intellectual property interests from a discovery or technology relating to health care. Dr. McKeon has received publishing royalties from a publication relating to health care.
Metha Apiwattanakul, MD Dr. Apiwattanakul has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Merck. Dr. Apiwattanakul has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for teva. Dr. Apiwattanakul has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Novartis.
K. Meng M. Tan, MD No disclosure on file
Sean J. Pittock, MD, FAAN Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arialys Therapeutics. The institution of Dr. Pittock has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Arialys. The institution of Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. The institution of Dr. Pittock has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. The institution of Dr. Pittock has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion/AstraZeneka. The institution of Dr. Pittock has received research support from NIH. The institution of Dr. Pittock has received research support from Alexion/AstraZeneka. The institution of Dr. Pittock has received research support from F. Hoffman/LaRoche/Genentech. Dr. Pittock has received intellectual property interests from a discovery or technology relating to health care. Dr. Pittock has received intellectual property interests from a discovery or technology relating to health care. Dr. Pittock has received publishing royalties from a publication relating to health care.
Bas Van Hoeve No disclosure on file
Vanda Lennon, MD, PhD The institution of Dr. Lennon has received research support from NIH. Dr. Lennon has received intellectual property interests from a discovery or technology relating to health care.
Christopher Gomez, MD, PhD Dr. Gomez has nothing to disclose.
Helenius J. Schelhaas, MD No disclosure on file
Lyell K. Jones, MD, FAAN Dr. Jones has received personal compensation in the range of $100,000-$499,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for 好色先生. Dr. Jones has received publishing royalties from a publication relating to health care. Dr. Jones has a non-compensated relationship as a member of the AAN Board of Directors with AAN that is relevant to AAN interests or activities. Dr. Jones has a non-compensated relationship as a Chair of the Mayo Clinic ACO Board of Directors with Mayo Clinic that is relevant to AAN interests or activities.
Berge A. Minassian, MD No disclosure on file
Nivetha Ramachandran, PhD No disclosure on file
Margherita Milone, MD, FAAN Dr. Milone has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology Genetics, AAN. The institution of Dr. Milone has received research support from Mayo Clinic, CCaTS-CBD. The institution of Dr. Milone has received research support from Mayo Clinic, SGP Award. The institution of Dr. Milone has received research support from MDA for Care Center grant. The institution of Dr. Milone has received research support from Regenerative medicine Minnesota.
Baziel G. van Engelen, MD, PhD, MA The institution of Dr. van Engelen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Fulcrum . The institution of Dr. van Engelen has received research support from Stichting Spieren voor Spieren. The institution of Dr. van Engelen has received research support from Prinses Beatrix Fonds. The institution of Dr. van Engelen has received research support from Dutch FSHD society. Dr. van Engelen has received intellectual property interests from a discovery or technology relating to health care.
Chiara Terracciano No disclosure on file
Sarah H. Ying, MD Dr. Ying has nothing to disclose.
Karla P. Figueroa Ms. Figueroa has nothing to disclose.
Vikram Shakkottai, MD, PhD The institution of Dr. Shakkottai has received research support from National Institutes of Health. Dr. Shakkottai has received publishing royalties from a publication relating to health care.